These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10068678)

  • 1. Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice.
    MacKenzie KL; Dolnikov A; Millington M; Shounan Y; Symonds G
    Blood; 1999 Mar; 93(6):2043-56. PubMed ID: 10068678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.
    Pear WS; Miller JP; Xu L; Pui JC; Soffer B; Quackenbush RC; Pendergast AM; Bronson R; Aster JC; Scott ML; Baltimore D
    Blood; 1998 Nov; 92(10):3780-92. PubMed ID: 9808572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia.
    Zhang X; Ren R
    Blood; 1998 Nov; 92(10):3829-40. PubMed ID: 9808576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic transforming potential of activated ras in chimeric mice.
    Hawley RG; Fong AZ; Ngan BY; Hawley TS
    Oncogene; 1995 Sep; 11(6):1113-23. PubMed ID: 7566971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model.
    Kelly LM; Liu Q; Kutok JL; Williams IR; Boulton CL; Gilliland DG
    Blood; 2002 Jan; 99(1):310-8. PubMed ID: 11756186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.
    Chan IT; Kutok JL; Williams IR; Cohen S; Kelly L; Shigematsu H; Johnson L; Akashi K; Tuveson DA; Jacks T; Gilliland DG
    J Clin Invest; 2004 Feb; 113(4):528-38. PubMed ID: 14966562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of murine JAK2V617F-positive myeloproliferative disease.
    Bumm TG; Elsea C; Corbin AS; Loriaux M; Sherbenou D; Wood L; Deininger J; Silver RT; Druker BJ; Deininger MW
    Cancer Res; 2006 Dec; 66(23):11156-65. PubMed ID: 17145859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant N-ras preferentially drives human CD34+ hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouse.
    Shen SW; Dolnikov A; Passioura T; Millington M; Wotherspoon S; Rice A; MacKenzie KL; Symonds G
    Exp Hematol; 2004 Sep; 32(9):852-60. PubMed ID: 15345287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
    Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
    PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of v-src induces a myeloproliferative disease in bone-marrow-reconstituted mice.
    Keller G; Wagner EF
    Genes Dev; 1989 Jun; 3(6):827-37. PubMed ID: 2568314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloproliferative disease and myelodysplastic syndrome induced by transplantation of bone marrow cells expressing mutant p53.
    Shounan Y; MacKenzie K; Dolnikov A; Miller M; Symonds G
    Leukemia; 1997 Oct; 11(10):1641-9. PubMed ID: 9324283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus.
    Hawley RG; Fong AZ; Burns BF; Hawley TS
    J Exp Med; 1992 Oct; 176(4):1149-63. PubMed ID: 1402659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice expressing Tel-FLT3, a constitutively activated form of FLT3, develop myeloproliferative disease.
    Baldwin BR; Li L; Tse KF; Small S; Collector M; Whartenby KA; Sharkis SJ; Racke F; Huso D; Small D
    Leukemia; 2007 Apr; 21(4):764-71. PubMed ID: 17268528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotent stem cells constitutively expressing a normal erythropoietin receptor give rise to normal hematopoiesis in lethally irradiated recipient mice.
    Lacout C; Dubart A; Vainchenker W; Duménil D
    Exp Hematol; 1996 Jan; 24(1):18-25. PubMed ID: 8536787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beta-galactosidase gene as a marker for hematopoietic reconstitution: individual cell analysis in a murine bone marrow transplantation model.
    Dolnikov A; Millington M; Beruter E; Shounan Y; Symonds G
    J Hematother Stem Cell Res; 2000 Oct; 9(5):659-72. PubMed ID: 11091490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term exposure to retrovirally expressed granulocyte-colony-stimulating factor induces a nonneoplastic granulocytic and progenitor cell hyperplasia without tissue damage in mice.
    Chang JM; Metcalf D; Gonda TJ; Johnson GR
    J Clin Invest; 1989 Nov; 84(5):1488-96. PubMed ID: 2478588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.
    Janssen JW; Steenvoorden AC; Lyons J; Anger B; Böhlke JU; Bos JL; Seliger H; Bartram CR
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9228-32. PubMed ID: 3122217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
    Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
    Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the transduction of pluripotent hematopoietic stem cells: long-term expression of a human adenosine deaminase gene in mice.
    Einerhand MP; Bakx TA; Kukler A; Valerio D
    Blood; 1993 Jan; 81(1):254-63. PubMed ID: 7678068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.